Trade Royalty Pharma plc - RPRX CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.2
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.022262 %(-$4.45)Trade size with leverage ~ $20,000.00Money from leverage ~ $19,000.00Go to platform: -0.02226%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position0.00004 %($0.01)Trade size with leverage ~ $20,000.00Money from leverage ~ $19,000.00Go to platform: 0.00004%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.022262 %
  (-$4.45)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: 0.00004 %
  ($0.01)

Key Stats

• Prev. Close: 56.2
• Open: 56.86
• 1-Year Change: 57.64%
• Day's Range: 56.44 - 56.95

Trade Royalty Pharma plc - RPRX

What is Royalty Pharma plc (RPRX)?

Royalty Pharma plc is a company engaged in acquiring and managing pharmaceutical royalties and related assets. Headquartered in the United Kingdom, Royalty Pharma provides capital to biopharmaceutical companies by purchasing royalty interests in approved and developmental drug products. The company's business model involves acquiring rights to receive future royalty payments, thereby supporting innovation and development in the pharmaceutical industry. Royalty Pharma's portfolio includes a diverse range of therapies across various therapeutic areas. The company operates globally, collaborating with pharmaceutical developers, investors, and other stakeholders. Its activities contribute to the financing and commercialization of pharmaceutical products, playing a role in the broader healthcare and life sciences sectors.

Royalty Pharma plc Stock Price Today: Live Overview

The price today is shaped by intraday market activity, as Royalty Pharma plc stands at $57.09. Throughout the session, it has moved between $56.3 and $57.05, with a daily percentage change of +0.7276%.

FAQ: Royalty Pharma plc (RPRX)

What is the current price of RPRX stock?

Royalty Pharma plc's last traded price is $57.09.

Does RPRX pay dividends?

Royalty Pharma plc pays dividends via cash distributions (if applicable).

Does RPRX have a formal corporate presence or regional headquarters in the UAE?

Royalty Pharma plc does not have an official office or subsidiary in the UAE and operates through partners and distributors.

What is RPRX best known for?

The company is most famous for acquiring and managing pharmaceutical royalties.

What assets are typically shown together with RPRX?

Commonly shown alongside RPRX: ClearPoint Neuro Inc, Global X S&P 500 Catholic Values ETF, Travelsky Technology